DXA in Children Treated with Bisphosphonates
In growing bone, administration of bisphosphonate yields differing effects based on medical condition, age, skeletal site measured, and therapeutic regimen.
OBJECTIVES
- Describe appearance of bisphosphonate treatment at measured body sites in treated children
- Examine BP treatment effects over time in children with different conditions
- Review bisphosphonate treatment approaches used in pediatrics.
LOCATION
Georgian room
Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT
Director of Radiology Research Operations
Nemours Children's Health
Heidi Kecskemethy, MS Ed, RDN, CBDT is the Enterprise Director of Radiology Research and is a Clinical Research Scientist at Nemours Children’s Health. She is based at Nemours Children’s Hospital Delaware in Wilmington, DE, USA. She has been certified by the ISCD since 2002, has served on various committees including chairing the Pediatric Committee, has served on two Pediatric Positions Development Committees (2013 and 2019), and is a past member of the ISCD Board.
Her scientific expertise is in pediatric nutrition and bone densitometry, with emphasis on bone assessment in patients with neuromuscular disabilities. She regularly presents at national and international meetings and has traveled the world providing instruction to healthcare professionals on pediatric bone assessment and the lateral distal femur DXA technique. She serves as a resource and educator for clinicians and researchers, providing guidance on pediatric bone density assessment and quality, and the conduct and design of human subject research. Heidi is also a Registered Dietitian with Board Certification in Pediatric Nutrition and has authored or co-authored over 40 peer-reviewed papers and 8 book chapters.
This activity has been approved by ASRT for 1.0 Category A continuing education credits.
If you want to claim credits for ACCME you will be able to at the end of the conference at this link:
https://learn.iscd.org/product...